Medicine and Dentistry
Diabetic Neuropathy
100%
Insulin Dependent Diabetes Mellitus
77%
Patient Referral
66%
Diabetes
58%
Prevalence
50%
Neuropathy
48%
Nerve Fiber
41%
Drug Therapy
41%
Prolactin
41%
Cohort Analysis
37%
Patient Care
37%
Disease
37%
Hyperprolactinemia
33%
Stenting
33%
Immunocompetent Cell
33%
Glomerular Filtration Rate
33%
Antihypertensive Agent
33%
Medical Specialty
33%
Environmental Factor
33%
Chronic Disease
33%
Endocrine Disease
33%
Premenopause
33%
Hirsutism
33%
Schwann Cell
33%
Metabolic Syndrome
33%
Renal Artery
33%
Patient with Type 1 Diabetes
33%
Glucose Tolerance
33%
Endophenotype
33%
Kidney Transplantation
33%
Physician
33%
Multiple Chronic Conditions
33%
Macrophage
25%
Erectile Dysfunction
25%
Systolic Blood Pressure
22%
Revascularization
22%
Renal Artery Stenosis
22%
Pulmonary Edema
22%
Congestive Heart Failure
22%
Population
19%
Diagnosis
19%
IgG4-Related Disease
16%
Infective Endocarditis
16%
Atrial Fibrillation
16%
Cushing Syndrome
16%
Phlebothrombosis
16%
Artery Thrombosis
16%
Oral Glucose Tolerance Test
16%
Polycystic Ovary Syndrome
16%
Carisoprodol
11%
Biochemistry, Genetics and Molecular Biology
Sex Difference
66%
Twin Study
66%
Body Mass
61%
Genetics
55%
Genetic Determinism
44%
Body Composition
38%
Population
38%
Spironolactone
33%
Body Size
33%
Prolactin
33%
Low Drug Dose
33%
Lipid
33%
Physical Activity
33%
Zygosity
33%
Endophenotype
33%
Randomized Clinical Trial
33%
Apolipoprotein
33%
Blood Pressure
33%
Genetic Divergence
33%
Waist Circumference
27%
Prevalence
16%
Multivariate Analysis
16%
Apolipoprotein B
16%
Apolipoprotein A1
16%
Apolipoprotein E
16%
Lipid Metabolism
16%
Triglyceride
16%
Body Fat
16%
High-Density Lipoprotein
16%
Genetic Variation
11%
Cross Sectional Study
11%
Creatinine Clearance
11%
Dyslipidemia
11%
Medical Record
11%
Insulin Resistance
11%
Glycemic Control
9%
Creatinine
9%
DNA Modification
5%
Genetic Difference
5%
Sedentary Lifestyle
5%
Quantitative Genetics
5%
Protein Content
5%
Dizygotic Twins
5%
Gene-Environment Interaction
5%
Genetic Marker
5%
Pharmacology, Toxicology and Pharmaceutical Science
Resistant Hypertension
77%
Spironolactone
66%
Non Insulin Dependent Diabetes Mellitus
66%
Antihypertensive Agent
47%
Prevalence
41%
Prolactin
41%
Randomized Clinical Trial
33%
Endocrine Disease
33%
Hirsutism
33%
Renovascular Disease
33%
Hyperprolactinemia
33%
Cohort Study
33%
Fibulin
33%
Erectile Dysfunction
29%
Placebo
25%
Defined Daily Dose
22%
Lung Edema
22%
Kidney Artery Stenosis
22%
Congestive Heart Failure
22%
Creatinine
19%
Ovary Polycystic Disease
16%
Cushing Syndrome
16%
Adverse Event
11%
Prospective Cohort Study
11%
Acute Heart Failure
11%
Depressed Blood Pressure
11%
Placebo-Controlled Study
9%
Cross-Sectional Study
8%
Isoniazid
8%
Obesity
8%
Corticotropin
8%
Sex Hormone Binding Globulin
8%
Hydroxyprogesterone
8%
Ovary Tumor
8%
21-Hydroxylase
8%
Androgen
8%
Prolactinoma
8%
Gynecomastia
5%
Hyperkalemia
5%
Tablet
5%
Antihypertensive Therapy
5%
Hypertension
5%